chitosan has been researched along with ranitidine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XG; Liu, CS; Liu, N; Liu, XY; Meng, XH; Yu, LJ; Zhou, HY | 1 |
| Gellert, P; Le, H; Schatzlein, A; Siew, A; Thiovolet, M; Uchegbu, I | 1 |
| Dorkoosh, FA; Faramarzi, MA; Foroutan, M; Ostad, SN; Rezayat, SM; Sadighi, A | 1 |
| Alkawareek, M; Bani-Jaber, A; Hamdan, I | 1 |
| Hooda, A; Jain, M; Kumar, V; Nanda, A; Rathee, P | 1 |
| Belhadji, L; HadjSadok, A; Moulai-Mostefa, N | 1 |
| Darbasizadeh, B; Farhadnejad, H; Foroughi-Nia, B; Motasadizadeh, H | 1 |
7 other study(ies) available for chitosan and ranitidine
| Article | Year |
|---|---|
Chitosan/cellulose acetate microspheres preparation and ranitidine release in vitro.
Topics: Administration, Oral; Cellulose; Chitosan; Delayed-Action Preparations; Drug Compounding; Excipients; Histamine H2 Antagonists; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Particle Size; Ranitidine; Solubility; Viscosity | 2005 |
Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles.
Topics: Adhesiveness; Animals; Anti-Ulcer Agents; Antibiotics, Antineoplastic; Antifungal Agents; Caco-2 Cells; Chitosan; Cyclosporine; Drug Carriers; Griseofulvin; Humans; Hydrophobic and Hydrophilic Interactions; Idarubicin; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Male; Nanoparticles; Quaternary Ammonium Compounds; Ranitidine; Rats; Rats, Wistar | 2012 |
Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Biological Transport; Caco-2 Cells; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Compounding; Furosemide; Humans; Intestinal Absorption; Intestinal Mucosa; Kinetics; Microscopy, Electron, Scanning; Models, Biological; Nanoparticles; Nanotechnology; Particle Size; Permeability; Polyphosphates; Ranitidine; Solubility; Technology, Pharmaceutical; Tight Junctions | 2012 |
The synthesis and characterization of fatty acid salts of chitosan as novel matrices for prolonged intragastric drug delivery.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Carriers; Kinetics; Laurates; Models, Chemical; Palmitates; Ranitidine; Sodium Bicarbonate; Solubility; Spectroscopy, Fourier Transform Infrared; Tablets; Technology, Pharmaceutical; Viscosity; Water | 2012 |
Optimization and evaluation of gastroretentive ranitidine HCl microspheres by using design expert software.
Topics: Adhesiveness; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Gastric Mucosa; Histamine H2 Antagonists; Microspheres; Models, Theoretical; Particle Size; Ranitidine; Software; Spectroscopy, Fourier Transform Infrared | 2012 |
Design and characterization of calcium-free in-situ gel formulation based on sodium alginate and chitosan.
Topics: Alginates; Calcium; Chitosan; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Excipients; Gels; Glucuronic Acid; Hexuronic Acids; Kinetics; Ranitidine; Rheology; Solubility; Suspensions; Viscosity | 2018 |
Tripolyphosphate-crosslinked chitosan/poly (ethylene oxide) electrospun nanofibrous mats as a floating gastro-retentive delivery system for ranitidine hydrochloride.
Topics: Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Gastrointestinal Tract; Nanofibers; Polyethylene Glycols; Polyphosphates; Ranitidine; Viscosity | 2018 |